Celcuity - Biotech Company with Promising Pipeline!

Business Driver: Celcuity (CELC) is a US-based biotechnology company in the clinical stage, specializing in the development of personalized cancer therapies and companion diagnostics. The main focus is on the drug "Gedatolisib", a so-called pan-PI3K/mTOR inhibitor that blocks the central signaling pathway PI3K/AKT/mTOR, thereby inhibiting the growth of certain tumors – particularly in hormone receptor-positive, HER2-negative breast cancer as well as other solid tumors. The company relies on the CELsignia diagnostic platform, which analyzes live...